CORRADO, ADDOLORATA
 Distribuzione geografica
Continente #
NA - Nord America 8.753
EU - Europa 5.980
AS - Asia 4.488
SA - Sud America 751
AF - Africa 84
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 10
Totale 20.078
Nazione #
US - Stati Uniti d'America 8.626
CN - Cina 1.641
IE - Irlanda 1.579
SG - Singapore 1.564
RU - Federazione Russa 1.019
UA - Ucraina 1.008
SE - Svezia 746
BR - Brasile 611
HK - Hong Kong 459
FR - Francia 400
IT - Italia 303
VN - Vietnam 293
DE - Germania 292
FI - Finlandia 182
GB - Regno Unito 138
IN - India 119
TR - Turchia 118
CZ - Repubblica Ceca 98
BD - Bangladesh 78
CA - Canada 64
AR - Argentina 53
IQ - Iraq 43
PL - Polonia 38
MX - Messico 37
AT - Austria 34
BE - Belgio 30
EC - Ecuador 26
NL - Olanda 26
ZA - Sudafrica 21
JP - Giappone 20
ID - Indonesia 19
UZ - Uzbekistan 18
ES - Italia 14
VE - Venezuela 14
EG - Egitto 12
LT - Lituania 12
PK - Pakistan 12
JO - Giordania 11
PY - Paraguay 11
CL - Cile 10
CO - Colombia 10
IR - Iran 10
SA - Arabia Saudita 10
MA - Marocco 9
PE - Perù 9
DK - Danimarca 8
EU - Europa 8
JM - Giamaica 8
RO - Romania 8
TN - Tunisia 8
AZ - Azerbaigian 7
PH - Filippine 7
SN - Senegal 7
CH - Svizzera 6
KE - Kenya 6
NZ - Nuova Zelanda 6
PT - Portogallo 6
AU - Australia 5
CI - Costa d'Avorio 5
LB - Libano 5
UY - Uruguay 5
CR - Costa Rica 4
DZ - Algeria 4
HR - Croazia 4
IL - Israele 4
KG - Kirghizistan 4
KZ - Kazakistan 4
NG - Nigeria 4
NP - Nepal 4
OM - Oman 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
GE - Georgia 3
GR - Grecia 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
MN - Mongolia 3
MY - Malesia 3
PA - Panama 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BY - Bielorussia 2
GT - Guatemala 2
HN - Honduras 2
KR - Corea 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LV - Lettonia 2
NO - Norvegia 2
PS - Palestinian Territory 2
RS - Serbia 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
Totale 20.059
Città #
Dallas 1.821
Dublin 1.576
San Jose 1.400
Singapore 775
Chandler 713
Jacksonville 660
Nyköping 500
Dearborn 455
Hong Kong 452
Ashburn 436
Beijing 387
Nanjing 300
Santa Clara 234
Lauterbourg 188
Princeton 163
Wilmington 157
Munich 132
The Dalles 124
Moscow 118
Los Angeles 114
Ho Chi Minh City 105
New York 102
Nanchang 95
San Mateo 90
Helsinki 87
Brno 79
Ann Arbor 77
Boardman 77
Shenyang 73
Hanoi 61
São Paulo 56
Des Moines 53
Tianjin 49
Hebei 46
Jiaxing 41
Shanghai 41
Guangzhou 39
Kunming 39
Foggia 37
London 36
Woodbridge 36
Changsha 35
Chicago 34
Columbus 31
Orem 31
Frankfurt am Main 30
Nuremberg 27
Zhengzhou 27
Brussels 24
Brooklyn 23
Hangzhou 23
Hillsboro 23
Jinan 22
Baghdad 21
Warsaw 21
Assago 20
Milan 19
San Francisco 19
Xi'an 19
Rio de Janeiro 18
Seattle 18
Toronto 17
Turku 17
Atlanta 16
Guayaquil 16
Montreal 16
Tokyo 16
Bari 15
Chennai 15
Da Nang 15
Lanzhou 15
Norwalk 15
Tashkent 15
Boston 14
Falkenstein 14
Rome 14
Amsterdam 13
Buffalo 13
Haiphong 13
Hefei 13
Ningbo 13
Olomouc 13
Vienna 13
Washington 13
Council Bluffs 12
Johannesburg 12
Phoenix 12
Taizhou 12
Belo Horizonte 11
Hanover 11
Paris 11
Stockholm 11
Brasília 10
Curitiba 10
Mexico City 10
Noci 10
Pune 10
Salvador 10
San Severo 10
Amman 9
Totale 13.014
Nome #
1,25OH-Vitamin D3 and IL-17 Inhibition Modulate Pro-Fibrotic Cytokines Production in Peripheral Blood Mononuclear Cells of Patients with Systemic Sclerosis 549
1,25OH-Vitamin D3 and IL-17 Inhibition Modulate Pro-Fibrotic Cytokines Production in Peripheral Blood Mononuclear Cells of Patients with Systemic Sclerosis 480
Primary versus systemic sclerosis-associated Raynaud’s phenomenon: relationship with clinical and environmental factors 217
A case of rhupus treated with filgotinib: A promising therapeutic perspective 198
Transthoracic Lung Ultrasound in Systemic Sclerosis-Associated Interstitial Lung Disease: Capacity to Differentiate Chest Computed-Tomographic Characteristic Patterns 192
SUBSTANCE P AND VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION BY PERIPHERAL BLOOD MONONUCLEAR CELLS DERIVING FROM PATIENTS WITH SYSTEMIC SCLEROSIS 159
Nailfold capillaroscopic findings in systemic sclerosis related lung fibrosis and in idiopathic lung fibrosis 157
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 153
Extra-skeletal effects of bisphosphonates. 151
Synovial fluid fibroblasts and lymphocytes support the osteoclastogenesis in human psoriatic arthritis 146
Dose-dependent metabolic effect of zoledronate on primary human osteoblastic cell cultures. 146
How to Assess Pulmonary Circulation and Right Heart Chambers in Systemic Sclerosis Patients? 145
Adult Scheuermann's disease as cause of mechanic dorsalgia 144
Nintedanib in Rheumatoid Arthritis–Related Interstitial Lung Disease: Real-World Safety Profile and Risk of Side Effects and Discontinuation 141
Abnormalities of insulin-like growth factor-I signaling and impaired cell proliferation in osteoblasts from subjects with osteoporosis 140
Effect of endothelin inhibition on lung fibroblasts on patients with systemic sclerosis 140
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study 140
Two cases of distal extremity swelling with pitting oedema in psoriatic arthritis: the different pathological mechanisms. 137
Pubic symphysis sclerosis in psoriatic arthritis. Case report. 134
Corticosteroids, a review. 129
Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis 129
Melkersson-Rosenthal syndrome in a patient with psoriatic arthritis receiving etanercept. 129
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry 128
THE ROLE OF TRANSIENT ELASTOGRAPHY (FIBROSCAN) IN THE STUDY OF LIVER FIBROSIS IN SSc 127
Anti-TNF-α and risk of infections: the experience in one center. 127
Extracellular Matrix modulates angiogenesis in physiological and pathological conditions 126
Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association. 126
COUNSELLING ON FAMILY PLANNING AND CONTRACEPTION, AND PREGNANCY OUTCOME IN WOMEN WITH RHEUMATIC DISEASES: A NATIONAL SURVEY OF 398 PATIENT-REPORTED QUESTIONNAIRES FROM 24 RHEUMATOLOGY CENTERS 126
Multiprofessional and intrahospital experience for diagnosis and treatment of pulmonary arterial hypertension 124
Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease. 124
TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis. 124
Obesity and Chronic Inflammation: Implications for Rheumatoid Arthritis, Spondyloarthritis, and Ulcerative Colitis 123
Role of altered osteoblastic expression of Dkk-1 in the pathogenesis of osteoarthritis and osteoporosis 123
Bisphosphonates: effects on osteoblast. 123
Italian Multicenter Real-World Study on the Twelve-Month Effectiveness, Safety, and Retention Rate of Guselkumab in Psoriatic Arthritis Patients 122
Anomalies de la capillaroscopie périunguéale au cours de la fibrose pulmonaire associée à la sclérodermie systémique et au cours de la fibrose pulmonaire idiopathique 122
Bone effects of biologic drugs in rheumatoid arthritis. 121
RANKL/OPG Ratio and DKK-1 Expression in Primary Osteoblastic Cultures from Osteoarthritic and Osteoporotic Subjects 121
Mitochondrial disease mimicking polymyositis: a case report 118
Combined effect of Neridronate and specific antibiotic therapy in a case of tuberculous spondylodiscitis 118
Comments on Addolorata Corrado et al. review “Extra-skeletal effects of bisphosphonates” 118
Type II diabetes in systemic sclerosis patients: insights from an observational, multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 116
In vitro and in vivo angiogenic activity of osteoarthritic and osteoporotic osteoblasts is modulated by VEGF and vitamin D3 treatment 116
AB0171 Anti-carbamylated protein antibodies in patients with systemic sclerosis: an intriguing association with skin involvement 116
IgA nephropathy in systemic lupus erythematosus. 115
Metabolic effects of zoledronate on primary human osteoblastic cell cultures 115
La coxalgia 115
Juvenile idiopathic arthritis: an update on clinical and therapeutic approaches 114
Anabolic therapy of induced osteoporosisin beta-thalassaemia major: case report and literature review 114
Anti-angiogenic effects of biotechnological therapies in rheumatic diseases 114
Extracellular matrix interactions with osteoblasts in osteoarthritis. A preliminary report 113
Osteocytes: central conductors of bone biology in normal and pathological conditions 113
Systemic effects of Wnt signaling 113
ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis - A EUSTAR analysis 113
Bisphosphonates and osteoarthritis 113
Preliminary data on post market safety profiles of covid 19 vaccines in rheumatic diseases: Assessments on various vaccines in use, different rheumatic disease subtypes, and immunosuppressive therapies: A two-centers study 113
EFFECTS OF DIFFERENT ANTI TNF ALPHA TREATMENTS ON LIPID AND CARBOHYDRATE METABOLISM IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS 112
Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) database 112
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis 112
Adipokines and Chronic Rheumatic Diseases: from Inflammation to Bone Involvement 112
Osteocalcin: Skeletal and extra-skeletal effects 111
Joint and tendon involvement predict disease progression in systemic sclerosis: A EUSTAR prospective study 111
Intestinal histological and ultrastructural inflammatory changes in spondyloarthropathy and rheumatoid arthritis. 110
Integrine expression on human osteoblasts in osteoarthritis 110
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. 110
Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: A EUSTAR analysis 110
SERUM 25(OH) VITAMIN D LEVELS, BODY MASS COMPOSITION AND EXTENT OF SKIN SCLEROSIS IN SYSTEMIC SCLEROSIS PATIENTS 110
THU0145 Changes in bone metabolism and trabecular bone score in patients with early rheumatoid arthritis 110
Osteoblast physiology in normal and pathological conditions 109
INHIBITORY EFFECT OF 1,25OH VITAMIN D ON IL-17 RELATED PRO-FIBROTIC CYTOKINES EXPRESSION IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH SYSTEMIC SCLEROSIS 109
Effects of Infliximab on human osteoblastic cells from rheumatoid arthrtis subjects 108
Expression of vascular endothelial growth factor in normal, osteoarthritic and osteoporotic osteoblasts. 108
Immunomodulatory effects of vitamin D in peripheral blood monocyte-derived macrophages from patients with rheumatoid arthritis 108
Osteoblast as a target of anti-osteoporotic treatment 108
Angiogenesis Dysregulation in Psoriatic Arthritis: Molecular Mechanisms 107
Reply to the letter by Baldeep Singh on the review entitled "Extra skeletal effects of bisphosphonates" 107
T cells support osteoclastogenesis in an in vitro model derived from human psoriatic arthritis 106
Anti-TNF-α effects on anemia in rheumatoid and psoriatic arthritis 106
Pathogenesis of ligaments ossification in spondyloarthritis: insights and doubts 105
ANTI-CARBAMYLATED PROTEIN ANTIBODIES IN PATIENTS WITH SYSTEMIC SCLEROSIS: AN INTRIGUING ASSOCIATION WITH SKIN INVOLVEMENT 105
AN EXEMPLAR BEHCET CASE, IN ALL ITS MULTISYSTEMIC FEATURES 105
Anti-angiogenic effects of anti–tumor necrosis factor α agents in the treatment of behçet disease 105
FRI0468 EFFECTS OF DIFFERENT VITAMIN D SUPPLEMENTATION SCHEMES IN POSTMENOPAUSAL WOMEN 105
Neridronate and osteoporotic and ostearthitic human osteoblasts 103
Impact of Systematic Isolation of Superior Vena Cava in Addition to Pulmonary Vein Antrum Isolation on the Outcome of Paroxysmal, Persistent, and Permanent Atrial Fibrillation Ablation: Results from a Randomized Study 103
Glucocorticoid induced risk of fractures 103
Effects of Infliximab on human osteoblastic cells from rheumatoid arthritis subjects 103
What have multicentre registries across the world taught us about the disease features of systemic sclerosis? 103
AB1099 Counselling on family planning and contraception, and pregnancy outcome in women with rheumatic diseases: a national survey of 398 patient-reported questionnaires from 24 rheumatology centers 103
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud’s phenomenon: a case–control study 103
Osteoporosis and rheumatic diseases 102
Cervical myelopathy caused by periodontoid synovial pannus in a patient with psoriatic arthritis: a case report. 102
Successful treatment of avascular bone necrosis of the knee with neridronate: a case report 102
Angiogenesis Dysregulation in the Pathogenesis of Systemic Sclerosis 102
Pathogenesis, clinical findings and management of acute and chronic gout. 102
Relationship between Body Mass Composition, Bone Mineral Density, Skin Fibrosis and 25(OH) Vitamin D Serum Levels in Systemic Sclerosis 101
Anti-cyclic-citrullinated-protein-antibodies in psoriatic arthritis patients: how autoimmune dysregulation could affect clinical characteristics, retention rate of methotrexate monotherapy and first line biotechnological drug survival. A single center retrospective study 100
Membranous nephropathy in rheumatoid arthritis: a case report. 99
Glucocorticoid induced risk of fractures. 99
Bilateral sequential central retinal vein occlusion associated with primary antiphospholipid syndrome 99
Totale 12.770
Categoria #
all - tutte 111.621
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.621


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022840 99 13 9 9 65 18 28 72 134 125 34 234
2022/20233.674 325 162 171 154 189 326 20 306 1.791 30 95 105
2023/2024739 108 39 45 30 44 140 15 28 1 38 19 232
2024/20253.011 167 24 67 113 109 496 280 206 738 215 296 300
2025/20267.779 378 813 1.996 740 301 313 1.268 679 481 422 165 223
2026/202719 19 0 0 0 0 0 0 0 0 0 0 0
Totale 20.799